Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report

BACKGROUND: Angiotensin receptor blockers (ARBs) are reported to provide direct protection to many organs by controlling inflammation and decreasing oxidant stress. Pioglitazone, an anti-diabetic agent that improves insulin resistance, was also reported to decrease inflammation and protect against a...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hirofumi, Sakamoto, Masaya, Hayashi, Takeshi, Iuchi, Hiroyuki, Ohashi, Kennosuke, Isaka, Tsuyoshi, Sakamoto, Noriko, Kayama, Yosuke, Tojo, Katsuyoshi, Yoshimura, Michihiro, Utsunomiya, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663745/
https://www.ncbi.nlm.nih.gov/pubmed/23635096
http://dx.doi.org/10.1186/1475-2840-12-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663745/
https://www.ncbi.nlm.nih.gov/pubmed/23635096
http://dx.doi.org/10.1186/1475-2840-12-71

Ejemplares similares